Literature DB >> 16903799

Schizophrenia: new pathological insights and therapies.

L Fredrik Jarskog1, Seiya Miyamoto, Jeffrey A Lieberman.   

Abstract

The neurodevelopmental hypothesis of schizophrenia posits an interaction between multiple susceptibility genes and one or more environmental insults in early life, resulting in altered brain development and the emergence of psychosis in early adulthood. Based on this framework, it has been argued that most neuropathological deficits observed in post mortem and neuroimaging studies of schizophrenia represent one or more lesions that originated in early life and remained static thereafter. However, recent longitudinal neuroimaging studies demonstrate a progressive component to the neuropathology of new-onset schizophrenia. This opens the possibility that the functional decline seen in many patients following the onset of illness may be halted or slowed. This review provides an update on developments in research on the neuropathology of schizophrenia and discusses recent advances in antipsychotic treatment and the potential impact on long-term outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16903799     DOI: 10.1146/annurev.med.58.060904.084114

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  36 in total

Review 1.  Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Authors:  A Guidotti; J Auta; Y Chen; J M Davis; E Dong; D P Gavin; D R Grayson; F Matrisciano; G Pinna; R Satta; R P Sharma; L Tremolizzo; P Tueting
Journal:  Neuropharmacology       Date:  2010-11-11       Impact factor: 5.250

2.  Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase B.

Authors:  Vincent Ries; Hsiao-Chun Cheng; Amy Baohan; Tatyana Kareva; Tinmarla F Oo; Margarita Rzhetskaya; Ross J Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Journal:  J Neurochem       Date:  2009-04-16       Impact factor: 5.372

3.  Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.

Authors:  Erika Pedrosa; Radu Stefanescu; Benjamin Margolis; Oriana Petruolo; Yungtai Lo; Karen Nolan; Tomas Novak; Pavla Stopkova; Herbert M Lachman
Journal:  Schizophr Res       Date:  2008-05-27       Impact factor: 4.939

Review 4.  Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior.

Authors:  Eduardo F Gallo
Journal:  Neurochem Int       Date:  2019-02-01       Impact factor: 3.921

5.  Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia.

Authors:  Yael Piontkewitz; Michal Arad; Ina Weiner
Journal:  Schizophr Bull       Date:  2010-05-03       Impact factor: 9.306

6.  Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study.

Authors:  Fatmahan Atalar; Tufan Tevfik Acuner; Naci Cine; Fatih Oncu; Dogan Yesilbursa; Ugur Ozbek; Solmaz Turkcan
Journal:  Behav Brain Funct       Date:  2010-05-28       Impact factor: 3.759

7.  GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Authors:  Jenifer L Vohs; R Andrew Chambers; Giri P Krishnan; Brian F O'Donnell; Sarah Berg; Sandra L Morzorati
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-23       Impact factor: 5.176

Review 8.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.

Authors:  Ryan J Van Lieshout; Lakshmi P Voruganti
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

Review 9.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

10.  Risperidone and haloperidol promote survival of stem cells in the rat hippocampus.

Authors:  Gerburg Keilhoff; Gisela Grecksch; Hans-Gert Bernstein; Thomas Roskoden; Axel Becker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-05       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.